APS Annual Meeting at Experimental Biology

Extracellular Vesicles as Targets for Cardiovascular Health

Symposium — Thursday, April 29, 2021 — 2:00 PM - 3:30 PM — Virtual Session, Room APS-6
The Physiological Society and APS — Chair: Susan Currie — Co-Chair:
Experimental Physiology

Cardiovascular disease remains the major cause of global mortality despite advances in disease treatment. Early detection of cardiovascular pathology is crucial for enhanced management and therapeutic treatment going forward. Extracellular vesicles (EVs) are emerging as potential candidates for novel biomarkers of cardiac injury, cardiotoxicity and also show potential as targets for therapeutic intervention. EVs play a role in intercellular communication across a number of cardiovascular cell types and, as such, may contribute to the progression of the pathophysiological process. This symposium will examine the current research strategies being considered for harnessing EVs in the diagnosis and treatment of various cardiovascular disorders. Particular focus will be given to the role EVs might serve as biomarkers of cardiac injury and how they may be used as therapeutic agents and drug delivery carriers going forward.


  • TBD
    Daret K. St Clair — Toxicology and Cancer Biology, University of Kentucky

  • TBD
    Lucy Norling — Microvascular Research, Queen Mary University of London

  • TBD
    Lorraine O'Driscoll — Pharmacy and Pharmaceutical Sciences, Trinity College Dublin

  • Session Chair
    Susan Currie — Institute of Pharmacy and Biomedical Sciences, University of Strathclyde Glasgow

Host Societies

Copyright © 2021 Experimental Biology (EB) | Experimental Biology® is a federally registered trademark of EB.